Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Percutaneous Transluminal Coronary Angioplasty (PTCA) is a procedure that helps restore blood flow to the blocked coronary artery without the requirement of open-heart surgery. GlobalData uses proprietary data and analytics to provide a comprehensive report on the ptca balloon catheters devices market, including market shares of different players within Brazil. Buy the latest report here.
Smarter leaders trust GlobalData
In 2022, GlobalData’s Market Model methodology determined that the leading player in the ptca balloon catheters market in Brazil was Abbott Laboratories followed by Boston Scientific, B. Braun Melsungen, Koninklijke Philips, Medtronic, Terumo, Biotronik SE, Meril Life Sciences and Teleflex.
In this procedure, a balloon at the end of a catheter is expanded to open the blocked coronary artery by compressing the plaque. Types of PTCA balloon catheters include Standard Balloon Catheters, Cutting and Scoring Balloon Catheters and PTCA Drug-Coated Balloon Catheters. Cutting and scoring balloon catheters have microsurgical blades mounted longitudinally on the angioplasty balloon catheter. Standard Balloon Catheters are coronary catheters equipped with a balloon capable of expanding. A Drug Coated Balloon (DCB) Catheter is an anti-restenotic drug coated PTCA balloon catheter intended to prevent re-narrowing of the coronary arteries.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the ptca balloon catheters devices market within Brazil was expected to be over $20m in 2022.
For the latest complete market share analysis of ptca balloon catheters device market in Brazil, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
